Connect-Home: Alzheimer's Disease and Related Dementias
Recruiting · NCT06840587 · Interventional (participants receive a specific treatment) · Lead sponsor: University of North Carolina, Chapel Hill
View the official record on ClinicalTrials.gov →Interventions studied
Connect-Home ADRD
What this trial is about
This study is a parallel arm, cluster randomized trial (CRT) to test the efficacy of Connect-Home ADRD, a transitional care intervention focusing on Skilled Nursing Facility (SNF) patients with Alzheimer's disease and dementias and their caregivers during transitions from SNFs to home, assisted, living, and long-term care. The primary hypothesis is that the intervention will reduce caregiver strain (Aim 1) and patient neuropsychiatric symptoms (Aim 2).
Who can take part
Age range
19 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Patients:
- Ability to speak English
- Goal of discharge to home, assisted living, or long-term care
- Diagnosis of dementia
- Having a caregiver willing to participate
- Caregivers:
- Ability to speak English
- Legally authorized representative (LAR) who also provides support for the person with ADRD
- Inclusion criteria for SNFs:
- Location within 120 miles of UNC-Chapel Hill
- Admission of at least 75 SNF patients per year
Exclusion criteria
- Patients:
- Planned hospital readmission for procedures or treatments within 30 days post enrollment.
- Caregivers:
- LAR is a court-appointed guardian.
Where it is running
1 location listed across 1 US state.
- University of North Carolina at Chapel Hill - Chapel Hill, North Carolina, United States